Ji'an Medical recently disclosed that the 700 million acquisition of eDevice to enter the mobile medical growth program has received feedback from the regulatory authorities, and the CSRC has asked questions about the deeper dependence of the target company's major customers.
.jpg)
The newly released refinancing feedback from the China Securities Regulatory Commission shows that the recent issuance supervision department has reviewed the refinancing applications of six companies including Jiu'an Medical and Weilong. Among them, the feedback from Jiu'an Medical is quite noticeable, and the first article of the opinion points to the risk of the big customers of the target company.
According to the China Securities Regulatory Commission, eDevice's largest customer is the Medtronic Group. In 2014, 2015 and January to June 2016, the company's sales revenue from the Medtronic Group accounted for 77.81% of the total sales revenue, respectively. 30% and 94.53%, showing the increasing dependence of large customers.
eDevice is the company that Jiu'an Medical has set up to raise funds. At the end of June this year, Jiu'an Medical announced that the company intends to raise no more than 710 million yuan through non-public offering of shares, and the net proceeds will be used to acquire 100% of the equity of eDevice held by 17 counterparties such as Mark Bellerby. . Taking December 31, 2015 as the benchmark date, the value of the total equity of eDevice shareholders was estimated to be 673.105 million yuan using the income method, with a value-added rate of 664.55%. Jiu'an Medical believes that this transaction will further accelerate the company's transition to mobile healthcare.
Card Recognition Time Attendance
Chongqing Huifan Technology Co., Ltd , https://www.hfsecuritytech.com